Visceral adiposity and systemic inflammation in the obesity paradox in patients with unresectable or metastatic melanoma undergoing immune checkpoint inhibitor therapy: a retrospective cohort study
Background The obesity paradox is a topic of increasing interest in oncology and epidemiology research. Although this phenomenon has been observed in melanoma patients receiving immune checkpoint inhibitors, little is known about its mechanism. We aim to investigate the prognostic value of obesity a...
Main Authors: | Ji Hyun Lee, Jeeyun Lee, Sujin Hyung, Sang-Hee Choi |
---|---|
Format: | Article |
Language: | English |
Published: |
BMJ Publishing Group
2022-08-01
|
Series: | Journal for ImmunoTherapy of Cancer |
Online Access: | https://jitc.bmj.com/content/10/8/e005226.full |
Similar Items
-
Immune checkpoint inhibitors for unresectable or metastatic pleomorphic dermal sarcomas
by: Doris Helbig, et al.
Published: (2022-11-01) -
FDA approves tebentafusp-tebn for unresectable or metastatic uveal melanoma
by: Zainab Abbas, et al.
Published: (2023-09-01) -
Obesity paradox in patients with non‐small cell lung cancer undergoing immune checkpoint inhibitor therapy
by: Ji Hyun Lee, et al.
Published: (2023-12-01) -
Visceral adipose inflammation in obesity is associated with critical alterations in tregulatory cell numbers.
by: Jeffrey Deiuliis, et al.
Published: (2011-01-01) -
Netrin-1 Promotes Visceral Adipose Tissue Inflammation in Obesity and Is Associated with Insulin Resistance
by: Amaia Mentxaka, et al.
Published: (2022-10-01)